pharmaceuticals-and-healthcare

Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Insights, Forecast to 2025


Published On : Oct 2018

Category : Pharmaceutical

No. of Pages : 117 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.
In 2017, the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market based on company, product type, application and key regions.

This report studies the global market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in these regions.
This research report categorizes the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine include
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

Market Size Split by Type
Immune DTaP Vaccine
Therapy DTaP Vaccine
Market Size Split by Application
Adult
Pediatric

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025, including the definition, classification, and industry chain structure of Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global diphtheria tetanus and pertussis dtap vaccine market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Types (Product Category) in 2017
Figure Immune DTaP Vaccine Product Picture
Table Major Manufacturers of Immune DTaP Vaccine
Figure Therapy DTaP Vaccine Product Picture
Table Major Manufacturers of Therapy DTaP Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Application 2018-2025 (K Doses)
Figure Adult
Figure Pediatric
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Report Years Considered
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size 2016-2025 (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2016-2025 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Regions 2016-2025 (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2016-2025 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2016-2025
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers (2016-2018) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers in 2017
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Share by Manufacturers in 2017
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2016-2018) (USD/Dose)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Category
Table Date of International Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Type (2016-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type in 2017
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Type (2016-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type in 2017
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type 2013-2018 (USD/Dose)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2016-2025)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2016-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2025) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2016-2018) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2016-2018)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2017
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2025) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2016-2018) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2025) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2016-2018) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2017
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2025) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2016-2018) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2025) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2016-2025) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2016-2025) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2016-2018) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2017
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Sanofi Pasteur Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Protein Sciences Corporation Company Details
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Protein Sciences Corporation Recent Development
Table Novartis AG Company Details
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Novartis AG Recent Development
Table Seqirus Company Details
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Seqirus Recent Development
Table Merck Sharp & Dohme Corp Company Details
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Merck Sharp & Dohme Corp Recent Development
Table Astellas Pharma US, Inc Company Details
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Astellas Pharma US, Inc Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Pfizer Inc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Lanzhou Institute of Biological Products Co., Ltd Company Details
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table AstraZeneca Company Details
Table Emergent BioSolutions Inc Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Chain
Table Typical Suppliers of Key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Material
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Channels
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top